Opinion: The state’s RFK-proofing bill comes with a cost

Mandates like HB 2242 can lead to higher premiums as insurance companies absorb costs for new preventive services, affecting affordability statewide.

Elizabeth New says lawmakers need a better grasp of the cumulative cost of health coverage mandates they pass

Elizabeth New
Washington Policy Center

Washington state’s health insurance system is already weighed down by mandates and rising costs. House Bill 2242 reinforces both. It was one of the session’s more visible health care bills, pushed by the governor and the Office of the Insurance Commissioner (OIC).

Elizabeth New (Hovde), Washington Policy Center

Supporters framed the legislation as a defense of science. In reality, it is a declaration of independence from federal health officials in the other Washington, whom state Democrats do not trust. The bill preserves no-cost insurance coverage for preventive services under state authority, even if federal recommendations change. It does not require anyone to get vaccinated. But it does keep insurers on the hook for preventive services and immunizations without cost-sharing under rules set by Washington state rather than federal guidance.

That political motive was not hidden. Gov. Bob Ferguson said the state government needed to protect residents from “the chaos of the federal government.” State Insurance Commissioner Patty Kuderer celebrated the bill and said it would keep recommendations in the hands of medical experts rather than federal political appointees. But that framing ignores expert input that federal officials also receive and suggests one level of government is guided by science while the other is guided by politics. It also ignores a basic reality: science evolves, sometimes dramatically, as new evidence emerges. COVID-19 made that hard to ignore. And government recommendations do not become apolitical simply because they come from Washington state instead of Washington, D.C. The real effect of the bill is not to remove politics from health care, but to shift more authority to the state while keeping insurers on the hook for the cost.

While lawmakers congratulated themselves for RFK-proofing Washington, they gave too little attention to the more practical question: Who pays?

The answer is not mysterious. When the state requires insurers to cover services with no cost-sharing, those costs do not vanish. They are built into premiums, plan design and the broader cost of coverage. The Washington state Legislature already has a habit of talking about health care affordability while at the same time layering on new mandates. HB 2242 fits that pattern.

To be fair, there are good public-health arguments for the bill. Preventive care can improve health outcomes. Vaccine access can reduce more expensive problems later. But if lawmakers believe the bill’s long-term benefits justify the cost to consumers, they should have made that the lede and focus. Instead, much of the public case for HB 2242 was a rebuke to federal officials rather than a careful explanation of why this added mandate is worth the price.

The fiscal discussion around HB 2242 focused largely on administrative implementation, and the official fiscal note did the job of addressing state agency costs, including rulemaking by the OIC. Fiscal discussion did not meaningfully address the downstream effects on private insurance premiums.

Lawmakers need a better grasp of the cumulative cost of health coverage mandates they pass. Consumers understand it all too well because they see it every year in higher premiums and less affordable coverage.

The House bill report lists no opposition testimony and includes the Association of Washington Healthcare Plans among those testifying in support. That may reassure supporters, but it should not end the conversation. A bill can be politically convenient, regulator-approved and still contribute to a health care system that keeps getting more expensive for the people forced to live in it.

HB 2242 is not a vaccine mandate, as some feared. It is another state coverage mandate enacted in the language of resistance politics. Many lawmakers wanted to show they trust government in Olympia more than government in Washington, D.C. Fine. But the stronger defense of this bill would have focused on public health, long-term savings and a clear justification for those mandated costs. In a system already bloated with mandates, middlemen and political jabs, affordability deserves more than an afterthought.

Elizabeth New is the director of the Centers for Health Care and Worker Rights at the Washington Policy Center. She is a Clark County resident.

Under the Grok Lens

Analysis created with Grok

This independent analysis was created with Grok, an AI model from xAI. It is not written or edited by ClarkCountyToday.com and is provided to help readers evaluate the article’s sourcing and context.

Quick summary

In this opinion column, Washington Policy Center analyst Elizabeth New criticizes House Bill 2242 for requiring health insurers to continue covering certain preventive services and immunizations without cost-sharing under state rules even if federal recommendations change. She argues the measure adds to the cumulative cost of insurance mandates and focuses more on political resistance than on a clear accounting of affordability effects for consumers.

What Grok notices

Explains the bill as preserving state-level no-cost coverage requirements for certain preventive services and immunizations even if federal guidance changes.
Frames the policy debate as a tradeoff between continuity of coverage and the cumulative cost of adding or maintaining insurance mandates.
Contrasts supporters’ public-health rationale with the columnist’s concern that costs do not disappear but instead shift into premiums paid by employers and consumers.
Notes the article’s focus on affordability analysis, particularly the argument that bill materials did not fully address downstream premium effects.
Suggests the broader issue is not only this single bill, but how repeated mandates may affect overall insurance costs when evaluated together over time.

Questions worth asking

How might state-level preventive care mandates affect insurance premiums over time when combined with other existing coverage requirements?
What are the advantages and risks of allowing state rules to continue no-cost coverage if federal scientific recommendations change?
What evidence shows that expanded no-cost preventive services reduce more expensive downstream treatment costs enough to offset higher premiums?
How have other states approached preventive-service mandates while trying to control affordability pressures for consumers and employers?
What role should detailed fiscal notes and mandate reviews play in helping lawmakers and the public assess the full consumer impact of health coverage bills?